102 related articles for article (PubMed ID: 8764591)
21. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
Hahn MK; Robertson D; Blakely RD
J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
[TBL] [Abstract][Full Text] [Related]
22. Effects of N-linked glycosylation on the creatine transporter.
Straumann N; Wind A; Leuenberger T; Wallimann T
Biochem J; 2006 Jan; 393(Pt 2):459-69. PubMed ID: 16167890
[TBL] [Abstract][Full Text] [Related]
23. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.
Buck KJ; Amara SG
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12584-8. PubMed ID: 7809082
[TBL] [Abstract][Full Text] [Related]
24. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
Diop NK; Hrycyna CA
Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
[TBL] [Abstract][Full Text] [Related]
25. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
26. Norepinephrine transporter expression in cholinergic sympathetic neurons: differential regulation of membrane and vesicular transporters.
Habecker BA; Klein MG; Cox BC; Packard BA
Dev Biol; 2000 Apr; 220(1):85-96. PubMed ID: 10720433
[TBL] [Abstract][Full Text] [Related]
27. Role of proline residues in the expression and function of the human noradrenaline transporter.
Paczkowski FA; Bryan-Lluka LJ
J Neurochem; 2004 Jan; 88(1):203-11. PubMed ID: 14675164
[TBL] [Abstract][Full Text] [Related]
28. Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells.
Mochizuki K; Kagawa T; Numari A; Harris MJ; Itoh J; Watanabe N; Mine T; Arias IM
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G818-28. PubMed ID: 17082223
[TBL] [Abstract][Full Text] [Related]
29. Discrete structural domains and cell-specific expression determine functional selectivity of the dopamine and norepinephrine transporters.
Buck KJ; Lorang D; Amara SG
NIDA Res Monogr; 1996; 161():154-75. PubMed ID: 8784850
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
31. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
[TBL] [Abstract][Full Text] [Related]
32. K+ amino acid transporter KAAT1 mutant Y147F has increased transport activity and altered substrate selectivity.
Liu Z; Stevens BR; Feldman DH; Hediger MA; Harvey WR
J Exp Biol; 2003 Jan; 206(Pt 2):245-54. PubMed ID: 12477895
[TBL] [Abstract][Full Text] [Related]
33. Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter.
Chen N; Trowbridge CG; Justice JB
J Neurochem; 1998 Aug; 71(2):653-65. PubMed ID: 9681456
[TBL] [Abstract][Full Text] [Related]
34. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
Buck KJ; Amara SG
Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
[TBL] [Abstract][Full Text] [Related]
35. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity.
Bauman PA; Blakely RD
Arch Biochem Biophys; 2002 Aug; 404(1):80-91. PubMed ID: 12127072
[TBL] [Abstract][Full Text] [Related]
36. Effect of N-glycosylation on the transport activity of the peptide transporter PEPT1.
Stelzl T; Baranov T; Geillinger KE; Kottra G; Daniel H
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G128-41. PubMed ID: 26585416
[TBL] [Abstract][Full Text] [Related]
37. The role of N-glycosylation in the targeting and activity of the GLYT1 glycine transporter.
Olivares L; Aragón C; Giménez C; Zafra F
J Biol Chem; 1995 Apr; 270(16):9437-42. PubMed ID: 7721869
[TBL] [Abstract][Full Text] [Related]
38. Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells.
Matherly LH; Angeles SM
Biochem Pharmacol; 1994 Mar; 47(6):1094-8. PubMed ID: 8147910
[TBL] [Abstract][Full Text] [Related]
39. Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells.
Apparsundaram S; Sung U; Price RD; Blakely RD
J Pharmacol Exp Ther; 2001 Nov; 299(2):666-77. PubMed ID: 11602680
[TBL] [Abstract][Full Text] [Related]
40. Selective labeling of neurotransmitter transporters at the cell surface.
Daniels GM; Amara SG
Methods Enzymol; 1998; 296():307-18. PubMed ID: 9779457
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
